VolitionRX Insider Sale: Secretary’s $0.21 Trade Adds Mild Warning to Weak Stock Signal
Insider selling at VolitionRX: what it signals for shareholders and potential value in a struggling biotech stock.
4 minutes to read
VolitionRX Ltd
VolitionRX Insider Surge: CEO and Key Executives Add Over 3.1 M Shares as Management Signals Confidence Amid 66% Stock Decline
VolitionRX insider buys signal management confidence amid a shaky stock, showing a 11% stake shift and potential upside for long‑term investors.
4 minutes to read
VolitionRx’s Secretary Buys 28,200 Shares Amid Widespread Insider Buying Surge, Hinting at Upcoming Catalyst?
Insider buying by VolitionRx’s top execs signals confidence in epigenetic diagnostics; assess upcoming milestones and market volatility before investing.
5 minutes to read